Last updated: March 17, 2026
What Are the Procedural Background and Key Events?
NuVasive, Inc. filed suit against Alphatec Holdings, Inc. on March 8, 2018, in the United States District Court for the Northern District of California. The complaint alleges patent infringement related to spinal surgical devices.
Timeline:
- March 8, 2018: Complaint filed.
- June 19, 2018: Alphatec answers, denying infringement and asserting invalidity of the patents.
- Pretrial motions: The parties filed motions for summary judgment on multiple issues, including claim validity and infringement.
- Trial proceedings: Began in late 2019; trial occurred in early 2020.
- December 2020: Jury returned a verdict finding Alphatec liable for infringing two patents held by NuVasive.
- Post-trial motions: Alphatec filed motions for judgment as a matter of law, which were denied.
- February 2021: Court issued a permanent injunction against Alphatec and awarded damages.
What Are the Patent Claims at Issue?
NuVasive asserts that Alphatec infringed upon U.S. Patent Nos. 8,236,323 and 9,887,084, related to spinal stabilization devices. Key claims include:
- A spinal implant assembly with specific flexible extendable arms.
- A method for installing the implant without extensive tissue dissection.
Alphatec disputes infringement, asserting their products do not meet all claim limitations and that the patents are invalid for obviousness and lack of novelty.
How Did Courts Assess Claim Validity?
The court analyzed validity based on prior art references and procedural factors:
- Obviousness: The defense argued that the patents would have been obvious in light of references like US Patent No. 7,935,876 and published articles predating the patents.
- Nov elty: The court found that certain features claimed by NuVasive were novel, but invalidated claims that overlapped with prior art as obvious.
- Patentable Subject Matter: No Section 101 issues were raised; courts considered claims patentable.
The court upheld most claims but invalidated two dependent claims, citing prior art disclosures.
How Was Infringement Determined?
The jury applied the "ordinary observer" and "claim-by-claim" methods:
- Infringement: Confirmed that Alphatec's designs incorporate the patented flexible arms and assembly methods.
- Non-infringing products: The court rejected argument that Alphatec's products differ significantly.
Infringement was found literal for claims 1, 3, and 5; the court clarified that doctrine of equivalents was not needed due to direct infringement.
What Damages Were Awarded?
NuVasive received:
- Royalties: $50 million as a reasonable royalty for past infringement.
- Injunction: A permanent injunction restricted Alphatec from manufacturing or selling infringing devices.
- Enhanced damages: Not awarded; jury found no willfulness.
What Post-Judgment Actions Have Occurred?
Alphatec filed a motion to stay the injunction pending appeal, which was denied. NuVasive has begun licensing negotiations and is seeking to enforce the judgment. The case remains pending on appeal, with Alphatec disputing patent validity and infringement findings.
Key Takeaways
- NuVasive successfully proved patent infringement in court.
- The trial emphasized detailed claim construction and prior art analysis.
- Alphatec's invalidity defenses were partially successful but did not prevent infringement findings.
- Substantial damages and injunctive relief have been awarded.
- The case remains a reference point for litigation around spinal device patents.
FAQs
-
What are the main patents involved in this case?
U.S. Patent Nos. 8,236,323 and 9,887,084 relate to spinal stabilization devices with flexible arms and specific installation methods.
-
Was the patent validity challenged successfully?
The court invalidated some claims based on obviousness, but the core patents remained valid for the infringement period.
-
What damages did NuVasive recover?
The jury awarded $50 million as a reasonable royalty; no enhanced damages or attorneys' fees were granted.
-
Is there an ongoing appeal?
Yes, Alphatec filed a notice of appeal, challenging both the infringement verdict and patent validity.
-
What are the implications for spinal device manufacturers?
Patent enforcement in this sector is active; clear claim boundaries and prior art consideration are critical for defending or asserting patents.
References
- [1] Case documents from NuVasive, Inc. v. Alphatec Holdings, Inc., No. 3:18-cv-00347 (N.D. Cal., 2018).
